loader
Please Wait
Applying Filters...

Looking for Fillers, Diluents & Binders? Find Fillers, Diluents & Binders Agents used in Riluzole to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 3,049Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Jai Radhe Sales

02 2Boai NKY Pharmaceuticals Ltd

03 8Gangwal Healthcare

04 5Nanjing Well Pharmaceutical

05 2Actylis

06 7Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

07 1DFE Pharma

08 4Finar

09 3Gangwal Chemicals

10 1Kima Chemical

11 10Microlex e.U

12 2Pharmatrans-Sanaq

13 3Pluviaendo

14 2Prachin Chemical

15 4Roquette

16 6Shanghai Shenmei Pharmaceutical Technology Co., Ltd

17 4Shanghai Welltone Material Technology Co., Ltd

18 6Sigachi Industries

19 1Ulanqab Kema New Material

20 4Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Grade : Oral (Pharma Grade)

Brand Name : KoVidone® K30

Excipient Details : KoVidone® K30 is used as a binder for tablets and capsules.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Ingredient(s) : Polyvinylpyrrolidone K30

Dosage Form : Capsule, Tablet

Category : Fillers, Diluents & Binders

Brand : KOVIDONE® K30

Applications : KoVidone® K30 is used as a binder for tablets and capsules.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Brand Name : Microlose™ M60 P60

Excipient Details : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : MICROLOSE™ M60 P60

Applications : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

08

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-101

Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-101

Applications : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

15

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-102

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

16

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : POVIDONE K-30

Applications : Povidone K30 is mainly used as binder for tablet and pellet,dissolving assistant for injection,flow assistant for capsule,dispersant for liquid medicine etc.

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Oral, Topical

arrow
blank

18

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

19

arrow
2024 ACI Convention
Not Confirmed

21

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pharmacel 101

Excipient Details : Pharmacel® 101 is a pharmaceutical excipient that acts as a pharmaceutical binder & filler for wet and dry granulation as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...

Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57

Grade : Oral

arrow

Brand : PHARMACEL 101

Applications : Pharmacel® 101 is a pharmaceutical excipient that acts as a pharmaceutical binder & filler for wet and dry granulation as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., JP, IP

Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57

Grade : Oral

arrow
blank

22

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-103

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

24

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

25

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

27

arrow
2024 ACI Convention
Not Confirmed

28

arrow
2024 ACI Convention
Not Confirmed

36

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank

37

arrow
2024 ACI Convention
Not Confirmed